• Atrial fibrillation is a co-morbidity for PCI patients that may complicate risk-benefit decisions for antithrombotic therapy.
• Recently developed PRECISE-DAPT score may be useful in judging the bleeding risk of atrial fibrillation patients undergoing PCI.
• Optimal tools to understand bleeding risk from both pharmacologic and device choices continue to be a need in the PCI population.

中文翻译：

---

PRECISE-DAPT：测量心房颤动患者是否有可能被拉得太薄的风险

• 心房颤动是 PCI 患者的一种共病，可能使抗血栓治疗的风险收益决策复杂化。
• 最近开发的 PRECISE-DAPT 评分可能有助于判断接受 PCI 的房颤患者的出血风险。
• PCI 人群仍然需要从药物和设备选择中了解出血风险的最佳工具。